111 Inc. (YI) - Kapitalisasi marang pendapatan

111.com.cn (YI) - logo korporat

111, Inc. integrates cloud services and telemedicine to optimize the patient journey. The price-to-sales ratio trend confirms this trajectory, where 0.00 represents the latest level. Limited pricing power due to Chinese government regulation is offset by the creation of a B2B ecosystem. Meanwhile, the aggressive implementation of IT architecture and predictive algorithms is digitizing the conservative pharmaceutical market.

Koefisien rega marang pendapatan: 111 Inc. (YI) kanggo 04.07.2022 - 13.11.2026

Rincian analitis lan laporan data perusahaan 111, Inc. (YI)

- rega pasar lan target rega analis:
Kutipan saham 111.com.cn|YI - Target median analis
- indikator kapitalisasi pasar:
Biji pasar 111 Inc.|YI - Total Nilai Perusahaan
- indikator nilai buku ekuitas:
Nilai Buku saben Saham 111, Inc.|YI - Pambiji Buku Bisnis|Rasio Nilai Pasar marang Nilai Buku 111.com.cn|YI - Nilai Total Aset Perusahaan
- indikator total utang lan likuiditas perusahaan:
Total Utang marang Modal 111, Inc.|YI - Koefisien utang jangka dawa marang modal|Utang jangka cendhak marang modal 111.com.cn|YI - Gunggung utang perusahaan|Rasio utang marang kapitalisasi buku 111 Inc|YI - Silihan lan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan 111, Inc.|Rasio cepet 111.com.cn
- indikator profitabilitas perusahaan lan kelipatan valuasi:
YI - Bathi resik|Proyeksi bathi mangsa ngarep 111, Inc.|YI - Koefisien rega marang bathi|Prakiraan rega marang bathi 111.com.cn|YI - Rega marang bathi kanthi panyesuaian wutah|Pangali EV/EBITDA 111 Inc.|YI - Bathi operasional EBITDA|Bathi resik saben saham (EPS TTM) 111, Inc.|YI - Bathi resik saben saham sajrone 12 wulan pungkasan|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan 111.com.cn|YI - Wutah bathi ing taun lumaku|Prakiraan konsensus wutah bathi saben saham kanggo taun ngarep 111, Inc.
- statistik dodolan lan pendapatan perusahaan:
YI - Pendapatan perusahaan|Prakiraan pendapatan perusahaan 111.com.cn|YI - Multiplikator P/S|Multiplikator forward rega marang pendapatan 111 Inc
Analisis umum perusahaan:111, Inc YI
Produk mawa merek 111, Inc.

Investors must determine whether the current increase in asset value masks an impending crash. This metric measures the market value per unit of trading turnover, allowing for the identification of asset overheating through the price-to-sales ratio. Analyzing this trend helps detect a loss of momentum prior to the publication of financial reports. For 111, Inc. (YI), this is critical due to price wars with tech behemoths that erode the value of every unit of revenue in B2B distribution.

Pesaing utama

Kapitalisasi marang pendapatan cvshealth.com CVS|Koefisien rega marang pendapatan MCK|COR - Kapitalisasi marang pendapatan|CAH (Cardinal Health Corp) - Rega marang dodolan|HSIC - Multiplikator P/S|Prestige Consumer Healthcare - Koefisien rega marang pendapatan|WGRX (Wellgistics Health) - Rasio rega marang pendapatan|Rasio rega marang dodolan China Jo-Jo Drugstores RDGT|Multiplikator P/S Universe Pharmaceuticals Inc.|Biodexa Pharmaceuticals (BDRX) - Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S 9zt.hk (HKPD)|Multiplikator P/S BIMI (BIMI Holdings Inc.)|China Jo-Jo Drugstores Inc. - Rasio rega marang pendapatan|Rasio kapitalisasi pasar marang pendapatan Walgreens (WBA)